A detailed history of Gamma Investing LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 3,476 shares of INVA stock, worth $59,752. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,476
Previous 2,262 53.67%
Holding current value
$59,752
Previous $34.5 Million 65.36%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$14.4 - $16.4 $17,481 - $19,909
1,214 Added 53.67%
3,476 $57 Million
Q1 2024

Apr 05, 2024

BUY
$14.56 - $16.78 $18,229 - $21,008
1,252 Added 123.96%
2,262 $34.5 Million
Q4 2023

Feb 01, 2024

BUY
$12.32 - $16.27 $12,443 - $16,432
1,010 New
1,010 $16.4 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.2B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.